Paul Keating, the architect of Australia's $4.4 trillion superannuation system, is pushing to merge parts of Centrelink with the private retirement savings sector. The radical proposal would mark the ...
Israeli biotech Chemomab Therapeutics (Nasdaq: CMMB) has agreed to merge with US precision medicine company Scipher Medicine, in a deal that will shift the combined business toward an AI-guided Phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results